Sepsis study in cancer patients
Part of Cancer, Infections clinical trials.
This trial studies sepsis (a severe infection response) in cancer patients. It aims to learn more about how sepsis affects people with cancer and how to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be admitted to the intensive care unit (ICU) with sepsis.
- You must have a sepsis diagnosis that includes a certain score (SOFA score of 2 or more).
- You or someone close to you must give written permission (consent) to join the study.
- You cannot join if your medical team thinks death is very close.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study is looking at how sepsis affects bone marrow to understand why some people get very sick. If you are in the ICU with a serious infection or another critical illness, you may be eligible to join.
Hear when a new Sepsis in Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.